These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24448120)

  • 21. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
    Bhatnagar A; Kanwar AJ; Parsad D; De D
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Betamethasone oral mini-pulse therapy compared with topical triamcinolone acetonide (0.1%) paste in oral lichen planus: A randomized comparative study.
    Malhotra AK; Khaitan BK; Sethuraman G; Sharma VK
    J Am Acad Dermatol; 2008 Apr; 58(4):596-602. PubMed ID: 18158199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can we consider silymarin as a treatment option for vitiligo? A double-blind controlled randomized clinical trial of phototherapy plus oral
    Jowkar F; Godarzi H; Parvizi MM
    J Dermatolog Treat; 2020 May; 31(3):256-260. PubMed ID: 30935260
    [No Abstract]   [Full Text] [Related]  

  • 24. Dose-ranging efficacy of new once-daily extended-release minocycline for acne vulgaris.
    Stewart DM; Torok HM; Weiss JS; Plott RT;
    Cutis; 2006 Oct; 78(4 Suppl):11-20. PubMed ID: 17436825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial.
    Ozolins M; Eady EA; Avery AJ; Cunliffe WJ; Po AL; O'Neill C; Simpson NB; Walters CE; Carnegie E; Lewis JB; Dada J; Haynes M; Williams K; Williams HC
    Lancet; 2004 Dec 18-31; 364(9452):2188-95. PubMed ID: 15610805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study.
    Leyden J; Thiboutot DM; Shalita AR; Webster G; Washenik K; Strober BE; Shupack J
    Arch Dermatol; 2006 May; 142(5):605-12. PubMed ID: 16702498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients.
    Radmanesh M; Saedi K
    J Dermatolog Treat; 2006; 17(3):151-3. PubMed ID: 16854754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of oral methotrexate and oral mini-pulse dexamethasone vs either agent alone in vitiligo treatment with follow up by dermoscope.
    ElGhareeb MI; Metwalli M; AbdelMoneim N
    Dermatol Ther; 2020 Jul; 33(4):e13586. PubMed ID: 32410362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study.
    Majid I
    Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):230-4. PubMed ID: 20831696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral minipulse therapy in vitiligo.
    Kanwar AJ; Dhar S; Dawn G
    Dermatology; 1995; 190(3):251-2. PubMed ID: 7599392
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of systemic steroids and phototherapy in the treatment of stable vitiligo: a randomized controlled trial.
    El Mofty M; Essmat S; Youssef R; Sobeih S; Mahgoub D; Ossama S; Saad A; El Tawdy A; Mashaly HM; Saney I; Helal R; Shaker O
    Dermatol Ther; 2016 Nov; 29(6):406-412. PubMed ID: 27528547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minocycline is not effective in systemic sclerosis: results of an open-label multicenter trial.
    Mayes MD; O'Donnell D; Rothfield NF; Csuka ME
    Arthritis Rheum; 2004 Feb; 50(2):553-7. PubMed ID: 14872498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A systematic review of case series and clinical trials investigating systemic oral or injectable therapies for the treatment of vitiligo.
    Jafarzadeh A; Pour Mohammad A; Khosravi M; Amiri S; Rasouli A; Keramati H; Goodarzi A
    Skin Res Technol; 2024 Mar; 30(3):e13642. PubMed ID: 38454597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
    Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Narrow-Band Ultraviolet B versus Oral Minocycline in Treatment of Unstable Vitiligo: A Prospective Comparative Trial.
    Siadat AH; Zeinali N; Iraji F; Abtahi-Naeini B; Nilforoushzadeh MA; Jamshidi K; Khosravani P
    Dermatol Res Pract; 2014; 2014():240856. PubMed ID: 25221600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitiligo: an update on systemic treatments.
    Searle T; Al-Niaimi F; Ali FR
    Clin Exp Dermatol; 2021 Mar; 46(2):248-258. PubMed ID: 33350506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
    Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of the therapeutic benefit of dexamethasone cyclophosphamide pulse versus only oral cyclophosphamide in phase II of the dexamethasone cyclophosphamide pulse therapy: a preliminary prospective randomized controlled study.
    Parmar NV; Kanwar AJ; Minz RW; Parsad D; Vinay K; Tsuruta D; Ishii N; Hashimoto T
    Indian J Dermatol Venereol Leprol; 2013; 79(1):70-6. PubMed ID: 23254732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial.
    Szczurko O; Shear N; Taddio A; Boon H
    BMC Complement Altern Med; 2011 Mar; 11():21. PubMed ID: 21406109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of clinical efficacy and safety of tobramycin/dexamethasone ophthalmic suspension 0.3%/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis/blepharoconjunctivitis.
    Torkildsen GL; Cockrum P; Meier E; Hammonds WM; Silverstein B; Silverstein S
    Curr Med Res Opin; 2011 Jan; 27(1):171-8. PubMed ID: 21138337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.